These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical analysis of operation combined chemotherapy for stage IIIa non-small cell lung cancer].
    Author: Wang W, Li H, Shang LQ, Li XC, Li J, Song WA, Wen F.
    Journal: Zhonghua Wai Ke Za Zhi; 2005 Nov 15; 43(22):1450-2. PubMed ID: 16318812.
    Abstract:
    OBJECTIVE: To study the therapeutic result of operation combined chemotherapy for stage IIIa non-small cell lung cancer. METHODS: From January 2000 to December 2003, the data of 83 cases with stage IIIa non-small cell lung cancer undergoing operation combined chemotherapy and 33 cases with stage IIIa non-small cell lung cancer undergoing non-operative therapy were retrospectively analyzed. The median survival time and the 1-, 2-, 3- year survival rates of the two groups were compared by the Kaplan-Meier method. RESULTS: The median survival time of the operation group was 20.3 months, and the 1-, 2-, 3- year survival rates were 85%, 70%, and 35% respectively. The median survival time of the non-operation group was 14.5 months and the 1-, 2-, 3- year survival rates were 75%, 33%, and 15% respectively. CONCLUSION: The therapeutic result of the operation combined chemotherapy for the stage IIIa non-small cell lung cancer is better than that of the non-operative therapy obviously.
    [Abstract] [Full Text] [Related] [New Search]